Patents Assigned to Obalon Therapeutics, Inc.
  • Patent number: 10350100
    Abstract: Devices and methods for treating obesity are provided, including intragastric devices and methods of fabricating, deploying, inflating, locating, tracking, monitoring, deflating, and retrieving the same. In one embodiment, a device includes a balloon capsule having a distal end, a catheter having a proximal end and a distal end, a connector, a light sensor, and a balloon valve. At least one optical fiber extends along the length of the interior of the catheter and through the valve such that a distal end of the optical fiber is positioned at a distal end of the balloon capsule when the catheter is placed within the balloon capsule, and such that a proximal end of the optical fiber can be received by the light sensor.
    Type: Grant
    Filed: March 16, 2017
    Date of Patent: July 16, 2019
    Assignee: Obalon Therapeutics, Inc.
    Inventors: Sheldon Nelson, Neil R. Drake
  • Patent number: 10335303
    Abstract: Devices and methods for treating obesity are provided. More particularly a device for assisting a patient in swallowing an intragastric balloon is provided, comprising an elongate tube, a gastric balloon assembly reversibly attached to an orifice of the elongate tube and comprising an inflation catheter engaged with a gastric balloon, a handle member, and an engagement subassembly comprising a female portion and a male portion and configured and arranged for threading the inflation catheter into and engaging the elongate tube.
    Type: Grant
    Filed: November 4, 2016
    Date of Patent: July 2, 2019
    Assignee: Obalon Therapeutics, Inc.
    Inventors: Mark C. Brister, Neil R. Drake
  • Patent number: 10327936
    Abstract: An implant configured for ingestion by a patient. After the implant has been swallowed by the patient and is disposed within the target location, e.g. the patient's stomach, an inflation subcomponent causes the implant to expand from a compact delivery state to an expanded, volume-occupying, deployed state. In the deployed state the implant creates a sensation of satiety in the patient stomach and thereby aids in limiting food intake and obesity. After a predetermined time a deflation subcomponent is actuated and the implant reduces in size so as to allow it to pass through the remainder of the patient's digestive track. The device may further incorporate tracking and visualization subcomponents, as well as pharmaceutical delivery subcomponents.
    Type: Grant
    Filed: December 5, 2016
    Date of Patent: June 25, 2019
    Assignee: Obalon Therapeutics, Inc.
    Inventors: Mark C. Brister, Nelson Quintana, Kaushik A. Patel, Neil R. Drake, Antonio C. Llevares, Dubravka Markovic, Andrew P. Rasdal, Amy D. L. VandenBerg
  • Patent number: 10264995
    Abstract: Devices and methods for treating obesity are provided. More particularly, intragastric devices and methods of fabricating, deploying, inflating, locating, tracking, monitoring, deflating, and retrieving the same are provided.
    Type: Grant
    Filed: December 3, 2014
    Date of Patent: April 23, 2019
    Assignee: Obalon Therapeutics, Inc.
    Inventors: Mark C. Brister, Neil R. Drake, Sheldon Nelson, Daniel J. Proctor
  • Patent number: 10085865
    Abstract: Intragastric volume-occupying devices and methods for treating obesity are provided. The devices, which are inflated by carbon dioxide, include an aluminum or silicon oxide barrier layer providing carbon dioxide retention and an alkylene vinyl alcohol polymer layer providing structural integrity in vivo.
    Type: Grant
    Filed: May 28, 2015
    Date of Patent: October 2, 2018
    Assignee: Obalon Therapeutics, Inc.
    Inventors: Mark C. Brister, Kaushik A. Patel, Andrew P. Rasdal, Nelson Quintana, Neil R. Drake, Antonio C. Llevares, Dubravka Markovic, Amy D. L. VandenBerg
  • Publication number: 20180110640
    Abstract: Devices and methods for treating obesity are provided. More particularly, intragastric devices and methods of fabricating, deploying, inflating, monitoring, and retrieving the same are provided.
    Type: Application
    Filed: May 25, 2016
    Publication date: April 26, 2018
    Applicant: Obalon Therapeutics, Inc.
    Inventors: Mark C. Brister, Neil R. Drake, Antonio C. Llevares, Sheldon Nelson, Daniel J. Proctor, Andrew P. Rasdal, Keoni John Sundseth, Amy D.L. VandenBerg, Betty Wong
  • Patent number: 9895248
    Abstract: Devices and methods for treating obesity are provided. More particularly, intragastric devices and methods of fabricating, deploying, inflating, locating, tracking, monitoring, deflating, and retrieving the same are provided.
    Type: Grant
    Filed: October 7, 2015
    Date of Patent: February 20, 2018
    Assignee: Obalon Therapeutics, Inc.
    Inventors: Mark C. Brister, Neil R. Drake, Sheldon Nelson
  • Patent number: 9827128
    Abstract: Devices and methods for treating obesity are provided. More particularly, intragastric devices and methods of fabricating, deploying, inflating, monitoring, and retrieving the same are provided.
    Type: Grant
    Filed: September 21, 2015
    Date of Patent: November 28, 2017
    Assignee: Obalon Therapeutics, Inc.
    Inventors: Mark C. Brister, Paul D. Faucher, Neil R. Drake, Andrew P. Rasdal, Matthew S. Lake, Dubravka Markovic, Amy D. L. VandenBerg, Antonio C. Llevares, Josefina Nider
  • Patent number: 9662239
    Abstract: Devices and methods for treating obesity are provided. More particularly, intragastric devices and methods of fabricating, deploying, inflating, monitoring, and retrieving the same are provided.
    Type: Grant
    Filed: May 4, 2016
    Date of Patent: May 30, 2017
    Assignee: Obalon Therapeutics, Inc.
    Inventors: Mark C. Brister, Paul D. Faucher, Neil R. Drake, Andrew P. Rasdal, Matthew S. Lake, Dubravka Markovic, Amy D. L. VandenBerg, Antonio C. Llevares, Josefina Nider
  • Patent number: 9539132
    Abstract: An implant configured for ingestion by a patient. After the implant has been swallowed by the patient and is disposed within the target location, e.g. the patient's stomach, an inflation subcomponent causes the implant to expand from a compact delivery state to an expanded, volume-occupying, deployed state. In the deployed state the implant creates a sensation of satiety in the patient stomach and thereby aids in limiting food intake and obesity. After a predetermined time a deflation subcomponent is actuated and the implant reduces in size so as to allow it to pass through the remainder of the patient's digestive track. The device may further incorporate tracking and visualization subcomponents, as well as pharmaceutical delivery subcomponents.
    Type: Grant
    Filed: August 26, 2014
    Date of Patent: January 10, 2017
    Assignee: Obalon Therapeutics, Inc.
    Inventors: Mark C. Brister, Nelson Quintana, Kaushik A. Patel, Neil R. Drake, Antonio C. Llevares, Dubravka Markovic, Andrew P. Rasdal, Amy D.L. VandenBerg
  • Patent number: 9468550
    Abstract: Devices and methods for treating obesity are provided. More particularly, intragastric devices and methods of fabricating, deploying, inflating, monitoring, and retrieving the same are provided.
    Type: Grant
    Filed: March 17, 2015
    Date of Patent: October 18, 2016
    Assignee: Obalon Therapeutics, Inc.
    Inventors: Mark C. Brister, Andrew P. Rasdal, Neil R. Drake, Amy D. L. VandenBerg
  • Publication number: 20160278662
    Abstract: Devices and methods for treating obesity are provided. More particularly, intragastric devices and methods of fabricating, deploying, inflating, locating, tracking, monitoring, deflating, and retrieving the same are provided.
    Type: Application
    Filed: December 3, 2014
    Publication date: September 29, 2016
    Applicant: Obalon Therapeutics, Inc.
    Inventors: Mark C. Brister, Neil R. Drake, Sheldon Nelson, Daniel J. Proctor
  • Patent number: 9351862
    Abstract: Devices and methods for treating obesity are provided. More particularly, intragastric devices and methods of fabricating, deploying, inflating, monitoring, and retrieving the same are provided.
    Type: Grant
    Filed: March 27, 2014
    Date of Patent: May 31, 2016
    Assignee: Obalon Therapeutics, Inc.
    Inventors: Mark C. Brister, Paul D. Faucher, Neil R. Drake, Andrew P. Rasdal, Matthew S. Lake, Dubravka Markovic, Amy D. L. VandenBerg, Antonio C. Llevares, Josefina Nider
  • Patent number: 9173758
    Abstract: Devices and methods for treating obesity are provided. More particularly, intragastric devices and methods of fabricating, deploying, inflating, monitoring, and retrieving the same are provided.
    Type: Grant
    Filed: September 14, 2012
    Date of Patent: November 3, 2015
    Assignee: Obalon Therapeutics, Inc.
    Inventors: Mark C. Brister, Paul D. Faucher, Neil R. Drake, Andrew P. Rasdal, Matthew S. Lake, Dubravka Markovic, Amy D. L. VandenBerg, Antonio C. Llevares, Josefina Nider
  • Patent number: 9072583
    Abstract: Intragastric volume-occupying devices and methods for treating obesity are provided. The devices, which are inflated by carbon dioxide, include an aluminum or silicon oxide barrier layer providing carbon dioxide retention and an alkylene vinyl alcohol polymer layer providing structural integrity in vivo.
    Type: Grant
    Filed: October 15, 2009
    Date of Patent: July 7, 2015
    Assignee: Obalon Therapeutics, Inc.
    Inventors: Mark C. Brister, Kaushik A. Patel, Andrew P. Rasdal, Nelson Quintana, Neil R. Drake, Antonio C. Llevares, Dubravka Markovic, Amy D. L. VandenBerg
  • Patent number: 9011477
    Abstract: Devices and methods for treating obesity are provided. More particularly, intragastric devices and methods of fabricating, deploying, inflating, monitoring, and retrieving the same are provided.
    Type: Grant
    Filed: May 5, 2014
    Date of Patent: April 21, 2015
    Assignee: Obalon Therapeutics, Inc.
    Inventors: Mark C. Brister, Andrew P. Rasdal, Neil R. Drake, Amy D. L. VandenBerg
  • Patent number: 8992561
    Abstract: Devices and methods for treating obesity are provided. More particularly, intragastric devices and methods of fabricating, deploying, inflating, monitoring, and retrieving the same are provided.
    Type: Grant
    Filed: May 25, 2012
    Date of Patent: March 31, 2015
    Assignee: Obalon Therapeutics, Inc.
    Inventors: Mark C. Brister, Andrew P. Rasdal, Neil R. Drake, Matthew S. Lake, Dubravka Markvoic, Amy D. L. VandenBerg, Antonio C. Llevares, Josefina Nider
  • Patent number: 8845674
    Abstract: An implant configured for ingestion by a patient. After the implant has been swallowed by the patient and is disposed within the target location, e.g. the patient's stomach, an inflation subcomponent causes the implant to expand from a compact delivery state to an expanded, volume-occupying, deployed state. In the deployed state the implant creates a sensation of satiety in the patient stomach and thereby aids in limiting food intake and obesity. After a predetermined time a deflation subcomponent is actuated and the implant reduces in size so as to allow it to pass through the remainder of the patient's digestive track. The device may further incorporate tracking and visualization subcomponents, as well as pharmaceutical delivery subcomponents.
    Type: Grant
    Filed: April 23, 2012
    Date of Patent: September 30, 2014
    Assignee: Obalon Therapeutics, Inc.
    Inventors: Mark C. Brister, Nelson Quintana, Kaushik A. Patel, Neil R. Drake, Antonio C. Llevares, Dubravka Markovic, Andrew P. Rasdal, Amy D. L. VandenBerg
  • Publication number: 20140243871
    Abstract: Devices and methods for treating obesity are provided. More particularly, intragastric devices and methods of fabricating, deploying, inflating, monitoring, and retrieving the same are provided.
    Type: Application
    Filed: May 5, 2014
    Publication date: August 28, 2014
    Applicant: Obalon Therapeutics, Inc.
    Inventors: Mark C. Brister, Andrew P. Rasdal, Neil R. Drake, Matthew S. Lake, Dubravka Markovic, Amy D.L. VandenBerg, Antonio C. Llevares, Josefina Nider
  • Publication number: 20140214066
    Abstract: Devices and methods for treating obesity are provided. More particularly, intragastric devices and methods of fabricating, deploying, inflating, monitoring, and retrieving the same are provided.
    Type: Application
    Filed: March 27, 2014
    Publication date: July 31, 2014
    Applicant: Obalon Therapeutics, Inc.
    Inventors: Mark C. Brister, Paul D. Faucher, Neil R. Drake, Andrew P. Rasdal, Matthew S. Lake, Dubravka Markovic, Amy D.L. VandenBerg, Antonio C. Llevares, Josefina Nider